Mikromol was born in a time of uncertainty, and out of a desire for progress and unification. Following the fall of the Berlin wall, two friends sitting in their labs realised that East German science and industry lacked critical quality controls and were lagging behind on technological innovation; and set out to provide access to tools which would enable unified quality control systems in drug release.
Through speaking with members of the pharmaceutical production community, our founders identified an unmet demand for ketoprofen and ibuprofen degradation standards, crucial to ensure medications sitting on people’s shelves remained safe. They rose to meet this need and resolved to build a world-leading catalogue of highly characterised quantitative primary API and impurity reference materials. This initiative became Mikromol.
From the handful of scientists creating those first compounds, our team grew steadily, developing a reputation for quality, designing, and executing complex reference standard syntheses, and identification of unknown impurities appearing during production runs and stability testing. We brought in talented chemists from across the world, establishing today’s first-class team of PhD and MSc scientists and laboratory technicians and ensuring the continued excellence of our dedicated analytical and synthesis departments.
Over the decades that followed, the collaborative spirit that defined our start has continued through our relationships with drug manufacturers and method developers to grow our understanding of your needs, so that today we can offer you one of the pharmaceutical industry’s broadest portfolios of reference standards and reference material services – helping you create ever better, safer, medicines.
In choosing Mikromol today, you choose a top-quality reference standard manufactured in an ISO 17025/17034 accredited facility to help you achieve your highest testing accuracy.
You choose Certificates of Analysis (COAs) that give you market-leading levels of detail – part of our commitment to thorough and transparent documentation that enables you to audit by trace and mitigate risk to your organisation.
You choose expert support and advice from a global team about use and storage, transport, and technical applications, whether for pharmacopoeial methods or internally developed protocols.
You choose a heritage forged in the fire of progress and unification.
You choose Mikromol.
NOUN VERB ADJECTIVE ADVERB PLURAL NOUN PERSONS NAME COUNTRY
